Archivio Istituzionale della RicercaFocal therapy has emerged as an interesting option for localized low- to intermediate-risk prostate cancer (PCa). Targeted microwave ablation (TMA) is a novel FT modality involving targeted delivery of microwave energy under multiparametric magnetic resonance imaging (MRI)/ultrasound guidance.
Safety and Feasibility of Transperineal Targeted Microwave Ablation for Low- to Intermediate-risk Prostate Cancer / Oderda, Marco; Marquis, Alessandro; Calleris, Giorgio; D'Agate, Daniele; Faletti, Riccardo; Gatti, Marco; Marra, Giancarlo; Gontero, Paolo. - In: EUROPEAN UROLOGY OPEN SCIENCE. - ISSN 2666-1683. - 46:(2022), pp. 3-7. [10.1016/j.euros.2022.10.004]
Safety and Feasibility of Transperineal Targeted Microwave Ablation for Low- to Intermediate-risk Prostate Cancer
Oderda, Marco;Calleris, Giorgio;Marra, Giancarlo;Gontero, Paolo
2022
Abstract
Focal therapy has emerged as an interesting option for localized low- to intermediate-risk prostate cancer (PCa). Targeted microwave ablation (TMA) is a novel FT modality involving targeted delivery of microwave energy under multiparametric magnetic resonance imaging (MRI)/ultrasound guidance.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Oderda2022_Safety and Feasibility of Transperineal Targeted Microwave Ablation for Low- to Intermediate-risk Prostate Cancer.pdf
accesso aperto
Tipologia:
2a Post-print versione editoriale / Version of Record
Licenza:
Creative commons
Dimensione
588.14 kB
Formato
Adobe PDF
|
588.14 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11583/2983455